Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial - Sibylle Loibl; Gong Tang; Valentina Nekljudova; Priya Rastogi; Sivaramakrishna Rachakonda; Mattea Reinisch; Joshua Acosta; Andreas Schneeweiss; Christie Hilton; Sabine Seiler; Rohit Bhargava; Thomas Karn; et al. (Nature Medicine, 2026)